Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin Levels of Postmenopausal Women With Low Bone Mass: A Multicenter, Randomized, Head-to-head Clinical Trial
Phase of Trial: Phase III
Latest Information Update: 01 Oct 2015
At a glance
- Drugs Denosumab (Primary) ; Zoledronic acid (Primary)
- Indications Postmenopausal osteoporosis
- Focus Biomarker; Pharmacodynamics
- Acronyms DenoZol
- 07 Jun 2017 Biomarkers information updated
- 01 Jan 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Sep 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.